SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-020881
Filing Date
2022-11-01
Accepted
2022-11-01 17:06:53
Documents
17
Period of Report
2022-10-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sabs-20221026.htm   iXBRL 8-K 71612
2 EX-10.1 sabs-ex10_1.htm EX-10.1 71760
3 EX-10.2 sabs-ex10_2.htm EX-10.2 66668
4 EX-99.1 sabs-ex99_1.htm EX-99.1 24097
5 GRAPHIC img1871078_0.jpg GRAPHIC 10467
  Complete submission text file 0000950170-22-020881.txt   426823

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sabs-20221026_def.xml EX-101.DEF 13467
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sabs-20221026_lab.xml EX-101.LAB 17250
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sabs-20221026_pre.xml EX-101.PRE 12759
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sabs-20221026.xsd EX-101.SCH 3214
11 EXTRACTED XBRL INSTANCE DOCUMENT sabs-20221026_htm.xml XML 6479
Mailing Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104
Business Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104 605-679-6980
SAB Biotherapeutics, Inc. (Filer) CIK: 0001833214 (see all company filings)

IRS No.: 853899721 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39871 | Film No.: 221351347
SIC: 2836 Biological Products, (No Diagnostic Substances)